Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,316,987 papers from all fields of science
Search
Sign In
Create Free Account
Nafenopin
Known as:
Propanoic acid, 2-methyl-2-(4-(1,2,3,4-tetrahydro-1-naphthalenyl)phenoxy)-
, Nafenopin [Chemical/Ingredient]
, Acid, Nafenoic
Expand
A peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an antihyperlipoproteinemic agent.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Narrower (2)
CH-13437
SU-13,437
Broader (2)
Hypolipidemic Agents
Peroxisome Proliferators
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin.
Awad G. Abdellatif
,
Véronique Préat
,
Joseph Vamecq
,
Robert Nilsson
,
Marcel Roberfroid
Carcinogenesis
1990
Corpus ID: 41257631
Using an initiation--selection--promotion protocol for induction of liver tumors in Wistar rats, the modulating action of various…
Expand
Highly Cited
1990
Highly Cited
1990
Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
U. Gerbracht
,
W. Bursch
,
+4 authors
R. Schulte‐Hermann
Carcinogenesis
1990
Corpus ID: 25951340
Phenotypically altered liver foci were produced in female Wistar rats by a single dose of N-nitrosomorpholine followed by…
Expand
Highly Cited
1989
Highly Cited
1989
Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
M. R. Nemali
,
M. Reddy
,
+4 authors
J. Reddy
Toxicology and Applied Pharmacology
1989
Corpus ID: 2249575
1988
1988
Induction of hepatic peroxisome proliferation in mice by lactofen, a diphenyl ether herbicide.
E. G. Butler
,
T. Tanaka
,
T. Ichida
,
H. Maruyama
,
A. Leber
,
G. Williams
Toxicology and Applied Pharmacology
1988
Corpus ID: 34098385
1986
1986
Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis.
V. Préat
,
J. de Gerlache
,
M. Lans
,
H. Taper
,
M. Roberfroid
Carcinogenesis
1986
Corpus ID: 22409061
In order to investigate whether different 'promoters' have the same qualitative and/or quantitative effects on rat…
Expand
Highly Cited
1984
Highly Cited
1984
Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella.
H. Glauert
,
J. Reddy
,
W. Kennan
,
G. Sattler
,
V. S. Rao
,
H. Pitot
Cancer Letters
1984
Corpus ID: 27649182
Highly Cited
1984
Highly Cited
1984
Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver.
W. Stäubli
,
P. Bentley
,
F. Bieri
,
E. Fröhlich
,
F. Waechter
Carcinogenesis
1984
Corpus ID: 25028803
The effect of nafenopin and phenobarbitone upon the distribution of gamma-glutamyltranspeptidase activity and epoxide hydrolase…
Expand
Highly Cited
1983
Highly Cited
1983
Peroxisome proliferation in primary cultures of rat hepatocytes.
T. Gray
,
B. Lake
,
J. Beamand
,
J. Foster
,
S. Gangolli
Toxicology and Applied Pharmacology
1983
Corpus ID: 20318055
1983
1983
Carnitine octanoyltransferase of mouse liver peroxisomes: properties and effect of hypolipidemic drugs.
S. Farrell
,
L. Bieber
Archives of Biochemistry and Biophysics
1983
Corpus ID: 19828371
Highly Cited
1977
Highly Cited
1977
The peroxisome proliferation-associated polypeptide in rat liver.
J. Reddy
,
N. S. Kumar
Biochemical and Biophysical Research…
1977
Corpus ID: 43016565
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required